Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT Therapeutics AS Director's Dealing 2021

Jun 7, 2021

3600_dirs_2021-06-07_05ea9f59-e917-4315-93e3-462ea740cdaf.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Notification of transactions by Primary Insiders and Close Associates

1 Details of the Primary Insider/Close Associate
a) Name Masha Strømme
2
a) Position/status The notification concerns
a Primary insider:
Masha Strømme,
PhD, Chair of Board
b) Initial notification/ Initial notification
Amendment
3 Details of EXACT Therapeutics AS, emission allowance market participant, auction platform,
auctioneer or auction monitor
a) Name EXACT Therapeutics
AS
b) LEI 2138006ZE5JAL39AGD55
4
a) Description of the Nature of the instrument: Share
financial instrument, type
of instrument Instrument of identification code (ISIN): NO
001
0852213
Identification code
b) Nature of the transaction Purchase
c) Price(s) and volume(s) Price(s) Volume(s)
20.804
per share
6,489
d) Aggregated information Price:
134,997.156
-
Aggregated volume
Volume: 6,489
-
Price
e) Date of the transaction 2021-06-04
f) Place of the transaction MERK –
Oslo Børs